Insulin sensitivity and β-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 1, 2005, Pages 168-174

  Bitnun, Ari ^a   Sochett, Etienne ^a   Dick, Paul T ^a   To, Teresa ^a   Jefferies, Craig ^a   Babyn, Paul ^a   Forbes, Jack ^b   Read, Stanley ^a   King, Susan M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDINAVIR; INSULIN; LOPINAVIR PLUS RITONAVIR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LYMPHOCYTE FUNCTION; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LIPIDS; MALE;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 12244272426     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0125     Document Type: Article

References (41)

1. Leow MK, Addy CL, Mantzoros CS 2003 Clinical review 159: human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies. J Clin Endocrinol Metab 88:1961-1976
2. Shevitz A, Wanke CA, Falutz J, Kotler DP 2001 Clinical perspectives on HIV-associated lipodystrophy syndrome: an update. AIDS 15:1917-1930
3. Bitnun A, Sochett E, Babyn P, Holowka S, Stephens D, Read S, King SM 2003 Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children. AIDS 17:1319-1327
4. Melvin AJ, Lennon S, Mohan KM, Purnell JQ 2001 Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors. AIDS Res Hum Retroviruses 17:1117-1123
5. Lainka E, Oezbek S, Falck M, Ndagijimana J, Niehues T 2002 Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy. Pediatrics 110:e56
6. Amaya RA, Kozinetz CA, McMeans A, Schwarzwald H, Kline MW 2002 Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J 21:405-410
7. Bockhorst J, Ksseiry I, Toye M, Chipkin SR, Stechenberg BW, Fisher DJ, Allen HF 2003 Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children with protease inhibitors. Pediatr Infect Dis J 22:463-465
8. Vigano A, Mora S, Testolin C, Beccio S, Schneider L, Bricalli D, Vanzulli A, Manzoni P, Brambilla P 2003 Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children. J Acquir Immune Defic Syndr 32:482-489
9. Brambilla P, Bricalli D, Sala N, Renzetti F, Manzoni P, Vanzulli A, Chiumello G, di Natale B, Vigano A 2001 Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. AIDS 15:2415-2422
10. Vink NM, van Rossum AM, Hartwig NG, de Groot R, Geelen S 2002 Lipid and glucose metabolism in HIV-1-infected children treated with protease inhibitors. Arch Dis Child 86:67
11. Jaquet D, Levine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, Levy-Marchal C 2000 Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS 14:2123-2128
12. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM 1991 Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 145:259-263
13. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
14. Marshall WA, Tanner JM 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303
15. Saad MF, Steil GM, Kades WW, Ayad MF, Elsewafy WA, Boyadjian R, Jinagouda SD, Bergman RN 1997 Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 46:1167-1171
16. Pacini G, Bergman RN 1986 MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122
17. Bergman RN, Ader M, Huecking K, Van Citters G 2002 Accurate assessment of β-cell function: the hyperbolic correction. Diabetes 51(Suppl 1):S212-S220
18. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartez MW, Neifing JL, Ward WK, Beard JC, Palmer JP 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
20. Cutfield WS, Jefferies CA, Jackson WE, Robinson EM, Hofman PL 2003 Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr Diabetes 4:119-125
21. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
22. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26(Suppl 1):S5-S20
23. Centers for Disease Control and Prevention 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 43:1-10
24. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
25. Bergman RN, Prager R, Volund A, Olefsky JM 1987 Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800
26. Beard JC, Bergman RN, Ward WK, Porte Jr D 1986 The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes 35:362-369
27. Cook JS, Hoffman RP, Stene MA, Hansen JR 1993 Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab 77:725-730
28. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV 1986 Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315:215-219
29. Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C 2002 Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS 16:F1-F8
30. van der Valk M, Bisschop PH, Romijn JA, Ackermans MT, Lange JM, Endert E, Reiss P, Sauerwein HP 2001 Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS 15:2093-2100
31. Dube MP, Edmondson-Melancon H, Qian D, Aqeel R, Johnson D, Buchanan TA 2001 Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients. J Acquir Immune Defic Syndr 27:130-134
32. Murata H, Hruz PW, Mueckler M 2000 The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem 275:20251-20254
33. Behrens GM, Boerner AR, Weber K, van den Hoff J, Ockenga J, Brabant G, Schmidt RE 2002 Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. J Clin Invest 110:1319-1327
34. Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M, Grunfeld C 2001 Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS 15:F11-F18
35. Koster JC, Remedi MS, Qiu H, Nichols CG, Hruz PW 2003 HIV protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes 52:1695-1700
36. Reaven GM 1995 Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486
37. Reaven GM 1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
38. Passalaris JD, Sepkowitz KA, Glesby MJ 2000 Coronary artery disease and human immunodeficiency virus infection. Clin Infect Dis 31:787-797
39. Arpadi SM, Cuff PA, Horlick M, Wang J, Kotler DP 2001 Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+-lymphocyte count and CD4+-lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J Acquir Immune Defic Syndr 27:30-34
40. Behrens G, Dejam A, Schmidt H, Balks HJ, Brabant G, Korner T, Stoll M, Schmidt RE 1999 Impaired glucose tolerance, β cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 13:F63-F70
41. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA 1999 Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- assodated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353:2093-2099